Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Intermediate I. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel Gould-Jacob and Suzuki coupling route for Penicinotam. Eliminates toxic cyanohydrin, offering cost reduction and scalable supply for agrochemical manufacturing.
Patent CN1662525A reveals a novel route for 1,2,4-triazolylmethyl-oxiranes, offering superior regioselectivity and simplified purification for agrochemical manufacturing.
Patent CN100386310C details a safe, high-yield route for oxalamides using oxalate esters. Ideal for API intermediates, offering cost reduction and scalable manufacturing.
Patent CN109912426B reveals a cost-effective route for (2R,5R)-1,6-diphenyl-2,5-hexanediamine. Discover scalable manufacturing solutions for HIV drug intermediates.
Advanced synthesis of Irbesartan key intermediates via mild amidine cyclization. High-purity pharma intermediates with optimized cost and scalable manufacturing processes.
Patent CN108148026A enables efficient FDCA production via carbonylation. Offers sustainable biomass sourcing and reduced processing steps for supply chain optimization.
Patent CN113527382B reveals a novel MPLA synthesis route using Nap protection. Achieve higher purity and cost reduction in vaccine adjuvant manufacturing with scalable methods.
Novel titanium-mediated route eliminates palladium catalysts, offering significant cost reduction and scalable production for high-purity pharmaceutical intermediates.
Patent CN113527050B reveals a novel Nap-protected MPLA intermediate synthesis. This method eliminates hydrogenation, ensuring high purity and scalable supply for vaccine adjuvant manufacturing.
Patent CN112794782B details a mild copper-catalyzed carboxylation of trifluoromethyl styrenes using CO2, offering a sustainable route for high-purity pharmaceutical intermediates with reduced costs.
Patent CN1364169A reveals a safer carbamylation process for Cefuroxime acid using dimethyl carbonate, offering high purity and reduced toxicity for antibiotic manufacturing.
Patent CN113150031A discloses a novel oxaspiro chiral phosphoric acid enabling >97% ee in asymmetric synthesis. Reliable supplier for high-purity pharmaceutical intermediates.
Patent CN103539733A reveals a biphasic solvent synthesis for high-purity Isoniazid Para-Aminosalicylate, offering superior stability and cost-effective manufacturing for global API supply chains.
Patent CN113548952A reveals a novel method achieving ≥98.5% purity pseudoionone by controlling prenol levels, offering significant cost reduction and supply reliability for vitamin and fragrance manufacturers.
Patent CN115260213A reveals a one-pot cefdinir synthesis improving yield and purity. Discover cost reduction in pharmaceutical intermediates manufacturing.
Patent CN115215802A details a novel purification method for Vitamin H intermediates, achieving 99% purity via isopropanol recrystallization, ensuring cost-effective supply chain solutions.
Patent CN111484459A details a Pd-catalyzed asymmetric hydrogenation method offering high enantioselectivity and green atom economy for pharmaceutical intermediates.
Patent CN110551059B reveals a metal-free, visible-light driven synthesis of 3-sulfonylspiro[4,5]trienones using DABSO, offering significant cost reduction and supply chain stability.
Patent CN106995374B enables catalyst-free oxygen oxidation for nitroaromatic acids. Delivers high purity, reduced waste, and reliable supply chain for pharmaceutical intermediates.
Novel Bacillus megaterium strain enables high-purity R-4-chloro-3-hydroxybutyrate production with reduced costs and environmental impact.